Conformal Coating for ElectronicsGERMANTOWN, WI – November, 2011 – Ellsworth Adhesives and DYMAX Corporation announced today the joint launch of E-MAX 903-E, a new light-cure conformal coating.

E-MAX 903-E will be distributed world-wide exclusively by Ellsworth Adhesives. It has been engineered to cure with UV and visible light using DYMAX’s broad-spectrum and LED curing equipment. The product also features a secondary moisture-cure mechanism for ambient cure in shadowed areas.  E-MAX 903-E offers several competitive advantages including high chemical resistance, low viscosity, and a tack-free cure immediately upon cooling after light exposure. 

E-MAX 903-E is now available to Ellsworth Adhesives’ customers in the product catalog and online in 30 ml syringes, one-liter bottles and five-gallon cans . The new product compliments Ellsworth Adhesives’ broad line of 100% solvent-free products from DYMAX, a leading manufacturer of light curing industrial adhesives and curing systems.

Roger Lee, President of Ellsworth Adhesives – ESR group, commented, “We are excited about the joint launch of E-MAX 903-E with DYMAX Corporation.  With exclusive distribution rights, our engineering sales force has become well-versed in the new product, and we are confident that E-MAX 903-E will exceed the requirements of our various customers in the electronics industries.”

About Ellsworth Adhesives
Ellsworth Adhesives is the world's largest distributor of adhesive products and equipment.  Ellsworth Adhesives is a value added supplier of adhesives, sealants, coatings, encapsulants, tapes, releases and lubricants from leading international manufacturers including 3M, Bostik, Dow Corning, Dymax, Emerson & Cuming, Fisnar, Loctite, Lord, Permabond, Techcon and many others and offers the most comprehensive level of technical expertise available.  Ellsworth Adhesives operates sales offices and warehouses in the United States, Canada, Mexico, Brazil, China, Hong Kong, Malaysia, Australia, France and Thailand.  Ellsworth Adhesives can be contacted directly at 1-800-888-0698 or by logging onto

Posted by Sean Fenske, Editor-in-Chief, MDT